Supernus Pharmaceuticals
SUPN
#5037
Rank
NZ$3.16 B
Marketcap
NZ$54.33
Share price
1.78%
Change (1 day)
-33.52%
Change (1 year)

EPS for Supernus Pharmaceuticals (SUPN)

EPS in 2026 (TTM): NZ-$1.33

According to Supernus Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$1.39. In 2025 the company made an earnings per share (EPS) of NZ-$1.24 a decrease over its 2024 EPS that were of NZ$2.45.

EPS history for Supernus Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$1.337.09%
2025NZ-$1.24-150.75%
2024NZ$2.45
2022NZ$2.0710.78%
2021NZ$1.86-57.68%
2020NZ$4.4112.09%
2019NZ$3.930.47%
2018NZ$3.9189.38%
2017NZ$2.07-38.59%
2016NZ$3.36534.48%
2015NZ$0.53-211.54%
2014NZ-$0.48-91.1%
2013NZ-$5.3439.46%
2012NZ-$3.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21-978.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$4.94-455.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47-4,164.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26-694.74%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$52.30-3,864.47%๐Ÿ‡บ๐Ÿ‡ธ USA